21096 ⎘
Medicinal preparations containing antigens or antibodies; Bacterial antigens streptococcus Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus Streptococcus
METHODS FOR PRODUCTION OF CAPSULAR POLYSACCHARIDE PROTEIN CONJUGATES FROM STREPTOCOCCUS PNEUMONIAE SEROTYPE 19F
#2COMBINATION VACCINES AGAINST CORONAVIRUS INFECTION, INFLUENZA INFECTION, AND/OR RSV INFECTION
#3VACCINATION AGAINST PNEUMOCCOCAL AND COVID-19 INFECTIONS
#4LIPIDATED TLR7/8 MODULATORS AS ADJUVANTS AND USES THEREOF
#5MULTIVALENT PNEUMOCOCCAL VACCINES
#6MULTIPLE ANTIGEN PRESENTING SYSTEM (MAPS) CROSS-LINKED USING A BIFUNCTIONAL FUSION PROTEIN AND ITS USE IN VACCINES PROTEIN AND ITS USE IN VACCINES
#7IMMUNOGENIC COMPOSITIONS AND USES THEREOF
#8TOPICAL NASAL PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PROPHYLAXIS OF CHRONIC RHINOSINUSITIS (CRS)
#9METHOD FOR THE PURIFICATION OF CAPSULAR POLYSACCHARIDES
#10Vaccines and Antibodies for the Treatment and Prevention of Neurodegenerative Disorders and Inflammation Related Health Conditions
#11Immunogenic Compositions of PEGylated Polysaccharide Compounds
#12TARGETING moDC TO ENHANCE VACCINE EFFICACY ON MUCOSAL SURFACE
#13IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF
#14IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF
#15PNEUMOCOCCAL CONJUGATE VACCINES WITH SAPONIN-BASED ADJUVANTS
#16FUSION PROTEIN AND VACCINE
#17CYCLOALKYNE DERIVATIZED SACCHARIDES
#18IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES
#19Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
#20STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND IMMUNOGENIC CONJUGATE THEREOF
#21INTRANASAL POLYSACCHARIDE CONJUGATE NANOMULSION VACCINES AND METHODS OF USING THE SAME
#22Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses Thereof
#23USE OF MATRIX BOUND VESICLES (MBV) AS VACCINE ADJUVANTS
#24STREPTOCOCCAL VACCINES AND METHODS FOR USE
#25POLYVALENT PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE COMPONENT AND APPLICATION THEREOF
#26METHOD OF IDENTIFYING A BIOLOGICALLY-ACTIVE COMPOSITION FROM A BIOFILM
#27Process for Producing of Vaccine Formulations With Preservatives
#28IMMUNOGENIC COMPOSITIONS AND METHODS FOR REDUCING TRANSMISSION OF PATHOGENS
#29MULTIVALENT PNEUMOCOCCAL VACCINES
#30MICROPARTICLES FROM STREPTOCOCCUS PNEUMONIAE AS VACCINE ANTIGENS
#31SACCHARIDE-POLYPEPTIDE CONJUGATE COMPOSITIONS AND METHODS OF USE THEREOF
#32STREPTOCOCCUS SUIS VACCINE COMPOSITION COMPRISING IMMUNOGENIC FUSION POLYPEPTIDES
#33PNEUMOCOCCAL CONJUGATE VACCINES AND METHODS OF USE THEREOF
#34Protein-Saccharide Conjugation with Sodium Cyanoborohydride
#35METHODS OF PRODUCING BIOCONJUGATES OF E. COLI O-ANTIGEN POLYSACCHARIDES, COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF
#36POLYVALENT VACCINES FOR STAPHYLOCOCCAL & STREPTOCOCCAL INFECTION
#37Immunogenic Compositions of Polysaccharide-Protein Pegylated Compounds
#38METHODS AND COMPOSITIONS RELATING TO IMMUNIZATION OF IMMUNE DISTINCT PATIENTS
#39Methods for Incorporating Azido Groups in Bacterial Capsular Polysaccharides
#40METHODS AND PARTICLES FOR MODULATING AN IMMUNE RESPONSE
#41IMMUNOGENIC FUSION PROTEIN
#42PROTEIN ANTIGENS THAT PROVIDE PROTECTION AGAINST PNEUMOCOCCAL COLONIZATION AND/OR DISEASE
#43OIL-BASED ADJUVANTS
#44MODIFIED BIOTIN-BINDING PROTEIN, FUSION PROTEINS THEREOF AND APPLICATIONS
#45A MAPS VACCINE TARGETING SALMONELLA ENTERICA SEROVARS
#46IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF
#47PNEUMOCOCCAL POLYPEPTIDE ANTIGENS
#48MULTIPLE ANTIGEN PRESENTING IMMUNOGENIC COMPOSITION, AND METHODS AND USES THEREOF
#49GROUP B STREPTOCOCCUS CAPSULAR POLYSACCHARIDE VACCINE AND METHODS OF USE
#50A METHOD TO PRODUCE A VACCINE AGAINST STREPTOCOCCUS SUIS AND THE SAID VACCINE
#51METHOD FOR TREATING A SKIN WOUND CONTAINING KLEBSIELLA PNEUMONIAE
#52Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition
#53COMPOSITIONS COMPRISING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES AND METHODS OF USE THEREOF
#54MULTIVALENT PNEUMOCOCCAL VACCINES
#55VACCINE INCLUDING NONENCAPSULATED STRAIN AS ANTIGEN
#56COMPOUNDS AND ADJUVANT FORMULATIONS USEFUL IN PNEUMOCOCCAL VACCINES
#57Glyconjugate Vaccines
#58COMPOSITIONS COMPRISING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES AND METHODS OF USE THEREOF
#59SYNTHETIC GLYCOCONJUGATE VACCINE PROTOTYPE AGAINST STREPTOCOCCUS SUIS
#60Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses Thereof
#61METHODS OF USE & COMPOSITIONS OF IBD, IBS, & ANTINEOPLASTICMICROBIAL THERAPEUTICS
#62Multivalent Pneumococcal Glycoconjugate Vaccines Containing Emerging Serotype 24F
#63A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS OF VARIOUS SEROTYPES
#64CONJUGATED VACCINE CARRIER PROTEINS
#65POLYSACCHARIDE COMPOSITIONS AND METHODS OF USE
#66METHODS FOR IMPROVING THE ADSORPTION OF POLYSACCHARIDE-PROTEIN CONJUGATES AND MULTIVALENT VACCINE FORMULATION OBTAINED THEREOF
#67Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
#68POLYPEPTIDE-ANTIGEN CONJUGATES WITH NON-NATURAL AMINO ACIDS
#69METHODS FOR MAKING POLYSACCHARIDE-PROTEIN CONJUGATES
#70STABILIZATION OF ADJUVANTED VACCINE COMPOSITIONS AND THEIR USE
#71A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS OF VARIOUS SEROTYPES
#72PURIFIED CAPSULAR POLYSACCHARIDES OF STREPTOCOCCUS PNEUMONIAE
#73Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
#74A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS OF VARIOUS SEROTYPES
#75IMMUNOGENIC COMPOSITIONS AND USES THEREOF
#76PROTECTIVE VACCINE ANTIGEN AGAINST STREPTOCOCCAL INFECTION
#77GLYCOSYLATED COMP PILIN VARIANTS, METHODS OF MAKING AND USES THEREOF
#78METHODS FOR PRODUCING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CARRIER PROTEIN CONJUGATES
#79IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES
#80MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION
#81VACCINE
#82NEOGLYCOCONJUGATES AS VACCINES AND THERAPEUTIC TOOLS
#83STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND IMMUNOGENIC CONJUGATE THEREOF
#84Minimal Sequons Sufficient for O-Linking Glycosylation
#85IMMUNOGENIC COMPOSITION CONTAINING AN ANTIGEN AND AN ADJUVANT COMPRISING AL-MOFS
#86A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS SEROTYPE 9, SEQUENCE TYPE 16
#87VACCINE FOR IMMUNOCOMPROMISED HOSTS
#88Personalized Site-Specific Immunomodulation
#89IDENTIFYING PATIENT POPULATIONS VULNERABLE TO VIRAL INFECTION AND METHODS OF INDUCING HETEROLOGOUS IMMUNITY IN SAME
#90Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
#91IMMUNOGENIC FUSION PROTEIN
#92Enhancing immunogenicity of polysaccharide-protein conjugates
#93VACCINE
#94LIPID NANOPARTICLE ADJUVANT COMPOSITION FOR PNEUMOCOCCAL CONJUGATE VACCINES
#95Attenuating bacterial virulence by attenuating bacterial folate transport
#96METHODS FOR PRODUCTION OF CAPSULAR POLYSACCHARIDE PROTEIN CONJUGATES FROM STREPTOCOCCUS PNEUMONIAE SEROTYPE 19F
#97Compositions comprising polysaccharide-protein conjugates and methods of use thereof
#98NANOEMULSION ADJUVANT COMPOSITION FOR PNEUMOCOCCAL CONJUGATE VACCINES
#99IMMUNOGENIC COMPOSITION
#100METHOD OF IDENTIFYING A BIOLOGICALLY-ACTIVE COMPOSITION FROM A BIOFILM
#101Immunogenic Composition Comprising Multivalent Streptococcus Pneumoniae Polysaccharide-Protein Conjugates
#102NOVEL COMPOSITION
#103VACCINES FOR THE TREATMENT AND PREVENTION OF SEASONAL AND EMERGING INFECTIONS
#104Antibacterial treatment method for a patient with a skin wound
#105IMMUNOGENIC GLYCOPROTEIN CONJUGATES
#106LIPIDATED FLIPR AND USES THEREOF IN VACCINE
#107() vaccine
#108Modified biotin-binding protein, fusion proteins thereof and applications
#109IMMUNOGENIC COMPOSITIONS FOR PRODUCING NEUTRALISING ANTIBODIES AGAINST SARS-COV
#110NOVEL CARRIERS AND CONJUGATION METHODS
#111PURIFICATION PROCESSES FOR POLYSACCHARIDES AND POLYPEPTIDE CONJUGATES THEREOF
#112Oil-based adjuvants
#113IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES
#114Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
#115PROTEOGLYCAN CONJUGATE AND APPLICATION THEREOF
#116STREPTOCOCCAL GlcNAc-LACKING GLYCOPOLYPEPTIDES, CELL WALL CARBOHYDRATES, STREPTOCOCCUS VACCINES, AND METHODS FOR MAKING AND USING THEM
#117Vaccine for protection against
#118MULTIVALENT PNEUMOCOCCAL VACCINES
#119IMMUNOGENIC PEPTIDE AGAINST GROUP A STREPTOCOCCUS
#120TRITERPENE SAPONIN SYNTHESIS, INTERMEDIATES AND ADJUVANT COMBINATIONS
#121VIRUSES ENGINEERED TO PROMOTE THANOTRANSMISSION AND THEIR USE IN TREATING CANCER
#122GLYCOCONJUGATION PROCESSES AND COMPOSITIONS
#123INFLUENZA VIRUSES WITH MUTANT PB2 GENE SEGMENT AS LIVE ATTENUATED VACCINES
#124GROUP B STREPTOCOCCUS POLYSACCHARIDE-PROTEIN CONJUGATES, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATES, AND USES THEREOF
#125Compositions comprising polysaccharide-protein conjugates and methods of use thereof
#126Ointment-based skin wound treatment method
#127NUCLEIC ACID CONSTRUCT, RECOMBINANT INFLUENZA VIRUS, METHOD FOR PREPARING A RECOMBINANT INFLUENZA VIRUS, COMPOSITION AND USE
#128METHOD FOR IMPROVING IMMUNOGENICITY OF PROTEIN/PEPTIDE ANTIGEN
#129MICROPARTICLES FROM STREPTOCOCCUS PNEUMONIAE AS VACCINE ANTIGENS
#130EXPRESSION OF PNEUMOCOCCAL SURFACE PROTEIN A (PSPA)
#131GROUP B STREPTOCOCCUS POLYSACCHARIDE-PROTEIN CONJUGATES, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATES, AND USES THEREOF
#132GBS FERRITIN NANOPARTICLES
#133GROUP A STREP IMMUNOGENIC COMPOSITIONS WITH POLYSACCHARIDE-PROTEIN CONJUGATES
#134COMPOSITIONS COMPRISING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES AND METHODS OF USE THEREOF
#135STREPTOCOCCAL VACCINES
#136IMMUNOGENIC COMPOSITIONS
#137Glyconjugate vaccines
#138subspecies lactis isolate WFLU-12 and use thereof
#139BACTERIAL IMMUNIZATION USING NANOPARTICLE VACCINE
#140Glycoconjugation process
#141Methods of producing bioconjugates of O-antigen polysaccharides, compositions thereof, and methods of use thereof
#142Immunogenic compositions for use in pneumococcal vaccines
#143CORONAVIRUS ANTIGEN COMPOSITIONS AND THEIR USES
#144IMMUNOGENIC COMPLEX FOR ELICITING PROTECTIVE IMMUNITY AGAINST GROUP B STREPTOCOCCUS
#145Immunogenic compositions of polysaccharide-protein pegylated compounds
#146CARRIER PROTEIN WITH SITE-DIRECTED MUTATION AND USE THEREOF IN PREPARATION OF VACCINE
#147PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC POLYSACCHARIDE-CARRIER PROTEIN CONJUGATES
#148MULTIVALENT PNEUMOCOCCAL VACCINE COMPOSITIONS COMPRISING POLYSACCHARIDE-PROTEIN CONJUGATES
#149PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC POLYSACCHARIDE-CARRIER PROTEIN CONJUGATES
#150Multivalent pneumococcal vaccines
#151COMPOSITIONS OF ALUM NANOPARTICLES FOR IMMUNOMODULATION AND METHODS FOR PRODUCING THE SAME
#152Protein antigens that provide protection against pneumococcal colonization and/or disease
#153Methods for producing capsular polysaccharide carrier protein conjugates
#154PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC POLYSACCHARIDE-CARRIER PROTEIN CONJUGATES
#155METHODS FOR MONITORING THE PROGRESS OF POLYSACCHARIDE SIZE-REDUCTION
#156Immunogenic composition
#157PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC POLYSACCHARIDE-CARRIER PROTEIN CONJUGATES
#158PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC POLYSACCHARIDE-CARRIER PROTEIN CONJUGATES
#159BIOINFORMATIC PROCESSES FOR DETERMINATION OF PEPTIDE BINDING
#160METHOD OF PURIFYING POLYSACCHARIDES
#161VACCINE COMPOSITION AGAINST STREPTOCOCCUS SUIS INFECTION
#162DOSAGE AND ADMINISTRATION OF A BACTERIAL SACCHARIDE GLYCOCONJUGATE VACCINE
#163IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USES THEREOF
#164IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USES THEREOF
#165STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF
#166VACCINE COMPOSITIONS AND METHODS FOR REDUCING TRANSMISSION OF STREPTOCOCCUS PNEUMONIAE
#167NOVEL IMMUNOGENS AND METHODS FOR DISCOVERY AND SCREENING THEREOF
#168Therapeutic Agent Effectiveness and its Route of Adminstration
#169PNEUMOCOCCAL CAPSULAR SACCHARIDE CONJUGATE VACCINE
#170Vaccine delivery method
#171A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS
#172Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
#173Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
#174Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
#175Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
#176Immunogenic Antigens
#177COMPOSITIONS COMPRISING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES AND METHODS OF USE THEREOF
#178Image processing of streptococcal infection in pharyngitis subjects
#179Immunogenic fusion protein
#180MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITIONS AND METHODS OF USING THE SAME
#181RHAMNOSE-POLYSACCHARIDES
#182AN IMMUNOGENIC SEROTYPE 35B PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE AND CONJUGATION PROCESS FOR MAKING THE SAME
#183Attenuating bacterial virulence by attenuating bacterial folate transport
#184METHODS OF TREATING PATIENTS WITH AN IMMUNOGENIC COMPOSITION THAT PROTECTS AGAINST S. PNEUMONIAE SEROTYPE 29
#185Method for treating a skin wound having a infection
#186CONJUGATE PRODUCTION
#187IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF
#188Immunopotentiator, immunotherapeutic pharmaceutical composition and its preparation and use
#189Pneumococcal surface proteins
#190GENE THERAPY METHODS
#191VACCINE
#192MATERIALS AND METHODS FOR THE PREPARATION OF BACTERIAL CAPSULAR POLYSACCHARIDES
#193SACCHARIDE-POLYPEPTIDE CONJUGATE COMPOSITIONS AND METHODS OF USE THEREOF
#194MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE VACCINE
#195Methods for making polysaccharide-protein conjugates
#196Immunogenic Antigens
#197Method of identifying a biologically-active composition from a biofilm
#198PNEUMOCOCCAL CONJUGATE VACCINE FORMULATIONS
#199Glycoconjugation processes and compositions
#200Methods for production of capsular polysaccharide protein conjugates from serotype 19F
#201Dimethyl Fumarate and Vaccination Regimens
#202BACTERIAL VACCINE
#203Vaccine for immunocompromised hosts
#204Vaccine against infection
#205Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24F
#206MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION
#207Tetanus toxoid and CCL3 improve DC vaccines
#208Pneumococcal dosing regimen
#209Identifying patient populations vulnerable to viral infection and methods of inducing heterologous immunity in same
#210Immunogenic Multiple Hetero-Antigen Polysaccharide-Protein Conjugates and uses thereof
#211Immunogenic compositions and uses thereof
#212NANOPARTICLES AND USES THEREOF
#213Multivalent pneumococcal polysaccharide-protein conjugate composition
#214Immunogenic Compositions for Use in Pneumococcal Vaccines
#215NOVEL PNEUMOCOCCAL VACCINE FORMULATIONS
#216Pharmaceutical composition comprising attenuated strains and use thereof
#217Compositions comprising polysaccharide-protein conjugates and methods of use thereof
#218Glycoconjugation process
#219METHODS OF USE & COMPOSITIONS OF IBD, IBS, & ANTINEOPLASTIC MICROBIAL THERAPEUTICS
#220Vaccine for protection against
#221Method for preparing live attenuated vaccine by irradiation and live attenuated vaccine composition prepared by the same
#222STREPTOCOCCAL VACCINES AND METHODS FOR USE
#223STREPTOCOCCAL VACCINE FORMULATIONS AND USES THEREOF
#224TARGETING moDC TO ENHANCE VACCINE EFFICACY ON MUCOSAL SURFACE
#225Purified capsular polysaccharides of
#226Multivalent pneumococcal vaccines
#227Multiple antigen presenting immunogenic composition, and methods and uses thereof
#228ENHANCING IMMUNOGENICITY OF STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES
#229ENHANCING IMMUNOGENICITY OF STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES
#230Glycosylated ComP pilin variants, methods of making and uses thereof
#231Vaccine to pathogenic immune activation cells during infections
#232Vaccine formulations comprising preservative
#233TRITERPENE SAPONIN SYNTHESIS, INTERMEDIATES AND ADJUVANT COMBINATIONS
#234PROCESS FOR PREPARING PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATES
#235Cycloalkyne Derivatized Saccharides
#236IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF
#237Methods for providing a homogenous solution of lyophilized mutant diptheria toxin in dimethylsulfoxide
#238METHODS FOR PRODUCING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CARRIER PROTEIN CONJUGATES
#239Combination vaccine
#240Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates from lyospheres
#241Dimethyl Fumarate and Vaccination Regimens
#242Multivalent Streptococcus Vaccines
#243Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
#244Vaccine
#245COMPOSITIONS COMPRISING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES AND METHODS OF USE THEREOF
#246Oil-based adjuvants
#247Streptococcal GlcNAc-lacking glycopolypeptides, cell wall carbohydrates, vaccines, and methods for making and using them
#248Streptococcal vaccine
#249capsular polysaccharides and immunogenic conjugate thereof
#250GROUP B STREPTOCOCCUS POLYSACCHARIDE-PROTEIN CONJUGATES, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATES, AND USES THEREOF
#251STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF
#252Mixtures of polysaccharide protein pegylated compounds
#253Multivalent VLP Conjugates
#254Immunogenic complex for eliciting protective immunity against group B
#255Neoglycoconjugates as vaccines and therapeutic tools
#256Multivalent pneumococcal polysaccharide-protein conjugate composition
#257ADJUVANT SYSTEM FOR ORAL VACCINE ADMINISTRATION
#258Vaccine for protection against
#259Immunogenic peptide against group a
#260capsular polysaccharides and conjugates thereof
#261Method for separation of protein and other impurities from microbial capsular polysaccharides
#262Vaccine delivery method
#263Vaccine composition against infection
#264Expression of pneumococcal surface protein a (PSPA)
#265Mucosal adjuvants and delivery systems
#266Modified biotin-binding protein, fusion proteins thereof and applications
#267Immunogenic compositions
#268VACCINE SYSTEM FOR VACCINE ADJUVANT
#269IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES
#270Comprehensive vaccine design for commensal disease progression
#271Immunogenic compositions and uses thereof
#272Multivalent pneumococcal polysaccharide-protein conjugate composition
#273Dimethyl fumarate and vaccination regimens
#274PNEUMOCOCCAL CONJUGATE VACCINE FORMULATIONS
#275Methods of producing bioconjugates of o-antigen polysaccharides, compositions thereof, and methods of use thereof
#276Glycoconjugation process
#277D-glycero-B-D-heptose 1-phosphate (HMP) conjugates and use for targeted immune modulation
#278Saccharide-polypeptide conjugate compositions and methods of use thereof
#279Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
#280Method for controlling polysaccharide molecular weight using carbon dioxide
#281Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
#282Method of producing a designer blood product, method of using a designer blood product, and diet for selectively enhancing blood profile
#283Vaccine to pathogenic immune activation cells during infections
#284Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
#285Composition comprising an antigen and a substituted imidazo[1,2-a]pyrimidine for enhancing human immune response
#286Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
#287Pharmaceutical composition comprising attenuated strains and use thereof
#288Influenza viruses with mutant PB2 gene segment as live attenuated vaccines
#289METHOD OF TREATMENT
#290Immunogenic glycoprotein conjugates
#291Glycoconjugation processes and compositions
#292Methods and compositions employing immunogenic fusion proteins
#293Immunogenic compositions for use in pneumococcal vaccines
#294Multivalent pneumococcal polysaccharide-protein conjugate composition
#295Multivalent pneumococcal polysaccharide-protein conjugate composition
#296METHODS FOR PRODUCTION OF CAPSULAR POLYSACCHARIDE PROTEIN CONJUGATES FROM STREPTOCOCCUS PNEUMONIAE SEROTYPE 19F
#297Multivalent pneumococcal vaccines
#298NANOPARTICLE-BASED COMPOSITIONS
#299Glycosylation method
#300Vaccine for protection against